# Trading Agent Specifications

Please follow this specification to implement a trading agent. You have to consume a Confluent Cloud Kafka Topics, which stream some trading signal. Each trading signal talk about a specific company. You have some Technical Indicators, the open,high,low,close candle for the last 15 minutes, a forecast and a LLM trading signal : BUY or HOLD or SELL, and a stop loss and taking profit.
Can you please write me a trading agent which consumer this kafka topics and call the corresponding Alpaca API to take order, (buy, sell or hold) ?

## Kafka Json Schema

{
  "additionalProperties": false,
  "properties": {
    "adx": {
      "connect.index": 20,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "atr": {
      "connect.index": 18,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "bb_lower": {
      "connect.index": 15,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "bb_mid": {
      "connect.index": 16,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "bb_upper": {
      "connect.index": 17,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "best_ask": {
      "connect.index": 28,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "best_bid": {
      "connect.index": 27,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "close": {
      "connect.index": 6,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "context": {
      "connect.index": 31,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "type": "string"
        }
      ]
    },
    "di_minus": {
      "connect.index": 22,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "di_plus": {
      "connect.index": 21,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "ema": {
      "connect.index": 10,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "exit_price": {
      "connect.index": 34,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "forecast_5d": {
      "connect.index": 35,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "type": "string"
        }
      ]
    },
    "forecast_result": {
      "connect.index": 30,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "additionalProperties": false,
          "properties": {
            "forecast": {
              "connect.index": 0,
              "oneOf": [
                {
                  "type": "null"
                },
                {
                  "items": {
                    "oneOf": [
                      {
                        "type": "null"
                      },
                      {
                        "additionalProperties": false,
                        "properties": {
                          "mean": {
                            "connect.index": 1,
                            "oneOf": [
                              {
                                "type": "null"
                              },
                              {
                                "connect.type": "float64",
                                "type": "number"
                              }
                            ]
                          },
                          "q10": {
                            "connect.index": 2,
                            "oneOf": [
                              {
                                "type": "null"
                              },
                              {
                                "connect.type": "float64",
                                "type": "number"
                              }
                            ]
                          },
                          "q50": {
                            "connect.index": 3,
                            "oneOf": [
                              {
                                "type": "null"
                              },
                              {
                                "connect.type": "float64",
                                "type": "number"
                              }
                            ]
                          },
                          "q90": {
                            "connect.index": 4,
                            "oneOf": [
                              {
                                "type": "null"
                              },
                              {
                                "connect.type": "float64",
                                "type": "number"
                              }
                            ]
                          },
                          "timestamp": {
                            "connect.index": 0,
                            "oneOf": [
                              {
                                "type": "null"
                              },
                              {
                                "connect.type": "int64",
                                "flink.type": "timestamp",
                                "flink.version": "1",
                                "type": "number"
                              }
                            ]
                          }
                        },
                        "title": "Record_forecast_result_forecast",
                        "type": "object"
                      }
                    ]
                  },
                  "type": "array"
                }
              ]
            },
            "metadata": {
              "connect.index": 1,
              "oneOf": [
                {
                  "type": "null"
                },
                {
                  "type": "string"
                }
              ]
            }
          },
          "title": "Record_forecast_result",
          "type": "object"
        }
      ]
    },
    "high": {
      "connect.index": 4,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "low": {
      "connect.index": 5,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "macd": {
      "connect.index": 12,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "macd_hist": {
      "connect.index": 14,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "macd_signal": {
      "connect.index": 13,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "obv": {
      "connect.index": 19,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "open": {
      "connect.index": 3,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "quant_signal": {
      "connect.index": 26,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "type": "string"
        }
      ]
    },
    "rsi": {
      "connect.index": 11,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "sharpe": {
      "connect.index": 23,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "signal": {
      "connect.index": 32,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "type": "string"
        }
      ]
    },
    "signal_score": {
      "connect.index": 24,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "int32",
          "type": "number"
        }
      ]
    },
    "signal_strength": {
      "connect.index": 25,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "sma": {
      "connect.index": 9,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "spread": {
      "connect.index": 29,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "stop_loss": {
      "connect.index": 33,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "symbol": {
      "connect.index": 0,
      "type": "string"
    },
    "volume": {
      "connect.index": 7,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "float64",
          "type": "number"
        }
      ]
    },
    "volume_ticks": {
      "connect.index": 8,
      "oneOf": [
        {
          "type": "null"
        },
        {
          "connect.type": "int64",
          "type": "number"
        }
      ]
    },
    "window_end": {
      "connect.index": 2,
      "connect.type": "int64",
      "flink.type": "timestamp",
      "flink.version": "1",
      "type": "number"
    },
    "window_start": {
      "connect.index": 1,
      "connect.type": "int64",
      "flink.type": "timestamp",
      "flink.version": "1",
      "type": "number"
    }
  },
  "required": [
    "symbol",
    "window_start",
    "window_end"
  ],
  "title": "Record",
  "type": "object"
}


## Example of Kafka Payload

``` json
{
  "symbol": "MRK",
  "window_start": 1786384800000,
  "window_end": 1786385700000,
  "open": 130.7,
  "high": 130.87,
  "low": 130.445,
  "close": 130.58,
  "volume": 2384044.0,
  "volume_ticks": 775,
  "sma": 130.01764999999997,
  "ema": 128.9842276278709,
  "rsi": 62.273140194332086,
  "macd": 0.5428161955554458,
  "macd_signal": 0.5397786004982985,
  "macd_hist": 0.003037595057147291,
  "bb_lower": 128.44038625857942,
  "bb_mid": 130.01764999999997,
  "bb_upper": 131.59491374142053,
  "atr": 0.42824603301834824,
  "obv": -3.6559028E7,
  "adx": 39.49477610441679,
  "di_plus": 31.760376082837062,
  "di_minus": 10.709389819931891,
  "sharpe": 0.01967959635263815,
  "signal_score": 6,
  "signal_strength": 73.1,
  "quant_signal": "BULLISH",
  "best_bid": 130.69483870967744,
  "best_ask": 130.71548387096772,
  "spread": 0.02064516129032214,
  "forecast_result": {
    "forecast": [
      {
        "timestamp": 1786386606472,
        "mean": 130.25
      }
    ],
    "metadata": "{\"model_name\":\"ttm\",\"pretrained_source\":\"ibm-granite/granite-timeseries-ttm-r2\",\"device\":\"cpu\",\"requested_horizon\":1,\"num_series\":1,\"context_length\":512,\"input_lengths\":[200]}"
  },
  "context": "Company: MRK (Merck & Company, Inc.)\n\n## Company report\n# Merck & Company, Inc. (MRK)\n\n## Identity\n- **Ticker** : MRK\n- **Name** : Merck & Company, Inc.\n- **Recommendation** : buy\n- **Shares outstanding** : 0\n- **Last updated** : 2026-08-10T18:18:23Z\n\n## Quote\n- **Current price** : 130.57\n- **Previous close** : 128.58\n- **Open** : 128.29\n- **Day high** : 130.98\n- **Day low** : 128.235\n- **Market cap** : 0\n- **Volume** : 2411635\n- **Avg volume 10d** : 8815120\n- **50d average** : 123.8526\n\n## 52-week range\n- **High** : 135.05\n- **Low** : 77.58\n\n## Ratios\n- **P/E** : 104.45601\n- **EPS** : 1.25\n- **Dividend yield** : 2.64\n- **Beta** : 0.211\n\n## Sentiment\n- **Sentiment score** : 0.575\n- **Confidence** : 0.66\n- **Analyzer** : keyword\n- **Trend** : stable\n- **Growth sentiment** : neutral\n- **Dividend safety** : stable\n- **Articles (7d / 30d)** : 10 / 10\n- **Positive / Neutral / Negative** : 6 / 4 / 0\n- **Key themes** : growth, gain, strong, beat, win\n- **Catalysts** : growth, beat, acquisition, expansion\n- **Risks** : —\n\n## Analyst guidance\n- **2026** — rating: buy (0 analysts)\n  - EPS (est / low / high) : N/A / N/A / N/A\n  - Revenue (est / low / high) : N/A / N/A / N/A\n  - Distribution : strong_buy 4, buy 15, hold 10, sell 0, strong_sell 0\n  - Updated : 2026-08-10T18:18:23.433679\n\n## News (10)\n### S&P 500 Companies' Quarterly Earnings Growth Eases Amid Healthcare Drop, Oppenheimer Says\n- **Date** : 2026-08-10T18:02:06\n- **Source** : MT Newswires\n- **Category** : earnings\n- **Sentiment** : neutral (impact 0, confidence 0.4)\n- **Keywords** : growth, drop\n- **Summary** : S&P 500 companies' quarterly earnings growth rate eased from a week ago amid a drop in the healthcar\n- **URL** : https://finance.yahoo.com/markets/stocks/articles/p-500-companies-apos-quarterly-180206082.html\n\n### IMCR Jumps 21.2% in 3 Months as Kimmtrak Growth Fuels More Momentum\n- **Date** : 2026-08-10T16:16:00\n- **Source** : Zacks\n- **Category** : company\n- **Sentiment** : positive (impact 1, confidence 0.9)\n- **Keywords** : growth, gain\n- **Summary** : Immunocore's 3-month gain reflects Kimmtrak growth and pipeline progress, but valuation and mixed signals temper the momentum case.\n- **URL** : https://finance.yahoo.com/markets/stocks/articles/imcr-jumps-21-2-3-161600739.html\n\n### Eli Lilly Stock's Next Climb Runs Through A Pill, Not Just An Injection\n- **Date** : 2026-08-10T16:01:32\n- **Source** : Trefis\n- **Category** : company\n- **Sentiment** : neutral (impact 0, confidence 0.3)\n- **Keywords** : —\n- **Summary** : The case for more upside rests on its obesity pill, and what changed is not the drug but who can now write it and who can now pay for it.\n- **URL** : https://www.trefis.com/articles/610756/eli-lilly-stocks-next-climb-runs-through-a-pill-not-just-an-injection/2026-08-10\n\n### IMCR Q2 Revenues Climb 18.3% as Kimmtrak Demand Helps Offset EPS Miss\n- **Date** : 2026-08-10T15:39:00\n- **Source** : Zacks\n- **Category** : earnings\n- **Sentiment** : positive (impact 0.75, confidence 0.8)\n- **Keywords** : miss, strong, beat, win\n- **Summary** : Immunocore's Q2 revenue beat reflects strong Kimmtrak demand, but an EPS miss and distributor stocking headwind cloud the near-term outlook.\n- **URL** : https://finance.yahoo.com/healthcare/articles/imcr-q2-revenues-climb-18-153900256.html\n\n### BMY Rallies 16.2% in Three Months: Buy, Sell or Hold the Stock?\n- **Date** : 2026-08-10T15:15:00\n- **Source** : Zacks\n- **Category** : company\n- **Sentiment** : positive (impact 1, confidence 0.9)\n- **Keywords** : gain, win\n- **Summary** : Bristol Myers Squibb's Growth Portfolio and pipeline support momentum, but generic headwinds and recent gains call for a cautious stance.\n- **URL** : https://finance.yahoo.com/healthcare/articles/bmy-rallies-16-2-three-151500081.html\n\n### The Two Divergent Paths Priced Into Eli Lilly Stock\n- **Date** : 2026-08-07T18:38:16\n- **Source** : Trefis\n- **Category** : industry\n- **Sentiment** : positive (impact 1, confidence 0.9)\n- **Keywords** : high\n- **Summary** : If you hold shares, you're already exposed to a potential future where the stock is either far higher or far lower, and the options market is pricing both as real possibilities.\n- **URL** : https://www.trefis.com/articles/610531/the-two-divergent-paths-priced-into-eli-lilly-stock/2026-08-07\n\n### These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks\n- **Date** : 2026-08-07T15:30:00\n- **Source** : Barrons.com\n- **Category** : company\n- **Sentiment** : neutral (impact 0, confidence 0.3)\n- **Keywords** : —\n- **Summary** : Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes for Merck, Moderna, Summit Therapeutics, and more.\n- **URL** : https://www.barrons.com/articles/biotech-stocks-to-buy-new-drugs-1b626dfc?siteid=yhoof2&yptr=yahoo\n\n### IOVA Q2 Earnings Beat, Stock Jumps 43% on Strong Amtagvi Uptake\n- **Date** : 2026-08-07T13:52:00\n- **Source** : Zacks\n- **Category** : earnings\n- **Sentiment** : positive (impact 1, confidence 0.9)\n- **Keywords** : rise, beat\n- **Summary** : Iovance rises 43% after Q2 results top estimates as Amtagvi sales beat forecasts, boosting revenues and prompting a review of full-year guidance.\n- **URL** : https://finance.yahoo.com/healthcare/articles/iova-q2-earnings-beat-stock-135200704.html\n\n### Merck (MRK) Could Be 3% Undervalued On Raised Outlook And Key Drug Approvals\n- **Date** : 2026-08-07T11:14:16\n- **Source** : Simply Wall St.\n- **Category** : earnings\n- **Sentiment** : positive (impact 1, confidence 0.9)\n- **Keywords** : strong\n- **Summary** : Merck (MRK) is back in focus after a run of product and earnings headlines. Fresh approvals and label expansion efforts for KEYTRUDA and ENFLONSIA now sit alongside a raised 2026 revenue outlook and recent acquisition charges. See our latest analysis for Merck. Merck’s share price has moved to US$128.37 after a strong run, with a 90 day share price return of 15.25% and a 1 year total shareholder return of 65.06%, suggesting momentum has been building as approvals, trial readouts and raised...\n- **URL** : https://finance.yahoo.com/healthcare/articles/merck-mrk-could-3-undervalued-111416271.html\n\n### Morning Bid: Dealjà vu\n- **Date** : 2026-08-07T10:43:13\n- **Source** : Reuters\n- **Category** : earnings\n- **Sentiment** : neutral (impact 0, confidence 0.3)\n- **Keywords** : —\n- **Summary** : By Anna Szymanski August 7 (Reuters) - Your weekly market recap, with reading, watching and listening recommendations from the ROI team From the Editor Tech earnings hogged the spotlight this week, as\n- **URL** : https://finance.yahoo.com/markets/stocks/articles/morning-bid-dealj-vu-104313750.html\n\n\n## Most relevant recent news\n- [2026-06-25 18:29:00.000] Merck stock hits 52-week high at 125.14 USD\nMerck & Co. Inc. (MRK) stock reached a 52-week high, hitting 125.14 USD, marking a significant milestone for the pharmaceutical giant. Over the past year, Merck’s stock has experienced a robust 58.52% increase, reflecting investor confidence and positive market sentiment surrounding the company’s performance and prospects. This uptick comes amid a broader rally in the healthcare sector, driven by strong earnings reports and strategic advancements in drug development. The stock’s climb to this 52\n\n- [2026-08-04 10:30:48.857] Merck &amp; Co Q2 Adj. EPS $(0.13) Beats $(0.27) Estimate, Sales $16.607B Beat $16.356B Estimate\nMerck &amp; Co (NYSE:MRK) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.27) by 51.85 percent. This is a 106.1 percent decrease over earnings of $2.13 per share from the\n\n- [2026-08-05 11:44:57.000] \nMerck $MRK Q2 2026 Earnings: Revenue Beat Highlights Pipeline Progress Amid Acquisition Costs\n\n$PFE $AZN $ABBV $JNJ $BMY $AMGN $LLY \nhttps://t.co/KgSLpYy7jW\n\n- [2026-08-04 10:42:00.000] Merck shares rise on big Q2 earnings beat, adjusted FY outlook\nThe company posted a loss per share of $0.13 for the quarter, topping the analyst estimate of a loss of $0.27. Revenue came in at $16.6 billion, up 4% excluding currency effects, ahead of the $16.41 billion consensus estimate.\n\nKeytruda and Keytruda Qlex sales totaled $8.4 billion, up 4% excluding currency effects, including $463 million from Keytruda Qlex. Winrevair sales rose 75% excluding currency effects to $588 million.\n\nMerck shares rose 1.4% in premarket trading by 06:42 ET.\n\n“We continue\n\n- [2026-08-04 10:42:00.000] Merck&Co earnings beat by $0.14, revenue topped estimates\nMerck&Co sees FY 2026 EPS of $2.66-$2.76 versus the analyst consensus of $2.76.\n\nMerck&Co’s stock price closed at $127.77. It is up 13.78% in the last 3 months and up 58.15% in the last 12 months.\n\nMerck&Co saw 0 positive EPS revisions and 15 negative EPS revisions in the last 90 days. See Merck&Co’s stock price’s past reactions to earnings\n\nStay up-to-date on all of the upcoming earnings reports by visiting\n\nGut instinct isn't enough. Our Fair Value calculator uses\n\n—plus thousands of other sto\n\n\n\n## Other company news (independent of the current technical signal)\n- [2026-08-04 10:30:48.857 / benzinga] Merck &amp; Co Q2 Adj. EPS $(0.13) Beats $(0.27) Estimate, Sales $16.607B Beat $16.356B Estimate\nMerck &amp; Co (NYSE:MRK) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.27) by 51.85 percent. This is a 106.1 percent decrease over earnings of $2.13 per share from the\n\n- [2026-08-05 11:44:57.000 / twitter] \nMerck $MRK Q2 2026 Earnings: Revenue Beat Highlights Pipeline Progress Amid Acquisition Costs\n\n$PFE $AZN $ABBV $JNJ $BMY $AMGN $LLY \nhttps://t.co/KgSLpYy7jW\n\n- [2026-08-04 10:42:00.000 / investing] Merck shares rise on big Q2 earnings beat, adjusted FY outlook\nThe company posted a loss per share of $0.13 for the quarter, topping the analyst estimate of a loss of $0.27. Revenue came in at $16.6 billion, up 4% excluding currency effects, ahead of the $16.41 billion consensus estimate.\n\nKeytruda and Keytruda Qlex sales totaled $8.4 billion, up 4% excluding currency effects, including $463 million from Keytruda Qlex. Winrevair sales rose 75% excluding currency effects to $588 million.\n\nMerck shares rose 1.4% in premarket trading by 06:42 ET.\n\n“We continue\n\n- [2026-08-07 21:30:33.000 / twitter] \n📄 $MRK · EARNINGS HIGHLIGHTS - Merck &amp; Co., Inc.\n\nMerck swung to a $(0.54) per-share loss in Q2 as R&amp;D spend surged to $9.7B, largely from the $6.8B Terns acquisition.\n\n📊 Rev $16.607B (+5.1%) · GAAP EPS $(0.54) · NI $(1.335B) · GM 73.5%\n🟢 Beat Estimates · EPS $-0.13 vs $-0.27\n\n- [2026-08-06 05:31:00.000 / investing] Merck KGaA Q2 adjusted profit rises 9%, hikes FY outlook\nclocked a stronger second-quarter adjusted profit on Tuesday, aided by strong performances in its life science and electronics divisions, with the company also raising its annual profit outlook.\n\nAdjusted earnings before interest, tax, depreciation and amortization rose 9.4% year-on-year to 1.6 billion euros ($1.85 billion).\n\nThis was on the back of net sales rising 3.4% to 5.43 billion euros, aided by strength in life science and electronics. Merck’s healthcare sales fell 3.4% in the quarter.\n\n\n\n- [2026-08-04 10:42:00.000 / investing] Merck&Co earnings beat by $0.14, revenue topped estimates\nMerck&Co sees FY 2026 EPS of $2.66-$2.76 versus the analyst consensus of $2.76.\n\nMerck&Co’s stock price closed at $127.77. It is up 13.78% in the last 3 months and up 58.15% in the last 12 months.\n\nMerck&Co saw 0 positive EPS revisions and 15 negative EPS revisions in the last 90 days. See Merck&Co’s stock price’s past reactions to earnings\n\nStay up-to-date on all of the upcoming earnings reports by visiting\n\nGut instinct isn't enough. Our Fair Value calculator uses\n\n—plus thousands of other sto\n\n- [2026-08-04 11:00:57.000 / twitter] \nMerck &amp; Co., Inc. $MRK — Q2 FY2026 Results 📊\n\n🟡 Revenue Beat, EPS Miss\n\nMerck's core business grew 5% but a $5.7B Terns acquisition charge turned EPS deeply negative — masking solid KEYTRUDA and WINREVAIR momentum.\n\n#Earnings #MRK https://t.co/TmBFqUy2kI\n\n- [2026-08-04 11:00:32.000 / twitter] \n$MRK Q2 2026 earnings: Revenue Beats, but Aggressive Pipeline Shopping Obliterates the Bottom Line\n\nMerck delivered solid 5% top-line growth ($16.6B) driven by a stable Keytruda franchise and a hyper-scaling Winrevair. However, earnings completely decoupled from operations as https://t.co/EiHxbwRnUC\n\n- [2026-08-03 16:35:31.000 / seeking-alpha] Pfizer, Merck Q2 preview: New growth bets face legacy headwinds\nHealthcare giants Pfizer ( PFE ) and Merck ( MRK ) are scheduled to report their quarterly earnings on Tuesday, with analysts expecting a decline in their bottom lines.\n\nThe consensus EPS estimate for Pfizer is $0.68 , representing a 12.8% year-on-year fall, while Merck is expected\n\n\n\n## Technical indicators (15m candle at 2026-08-10 18:00:00.000)\nclose=130.58, sma=130.01764999999997, ema=128.9842276278709, rsi=62.273140194332086, macd=0.5428161955554458, macd_signal=0.5397786004982985, bb_lower=128.44038625857942, bb_mid=130.01764999999997, bb_upper=131.59491374142053, atr=0.42824603301834824, adx=39.49477610441679, sharpe=0.01967959635263815, best_bid=130.69483870967744, best_ask=130.71548387096772, spread=0.02064516129032214, quant_signal=BULLISH (strength=73.1)\n\n## Model forecast (next step)\n([(2026-08-10 18:30:06.472, 130.25, NULL, NULL, NULL)], {\"model_name\":\"ttm\",\"pretrained_source\":\"ibm-granite/granite-timeseries-ttm-r2\",\"device\":\"cpu\",\"requested_horizon\":1,\"num_series\":1,\"context_length\":512,\"input_lengths\":[200]})",
  "signal": "BUY",
  "stop_loss": 128.4,
  "exit_price": 133.0,
  "forecast_5d": "[{\"day\":1,\"expected_close\":130.25,\"outlook\":\"A modest pullback is possible after the strong advance, while momentum remains bullish.\"},{\"day\":2,\"expected_close\":130.6,\"outlook\":\"Price is likely to stabilize above the short-term moving averages.\"},{\"day\":3,\"expected_close\":131.2,\"outlook\":\"Positive momentum and strong trend strength may support a retest of the upper Bollinger Band.\"},{\"day\":4,\"expected_close\":131.8,\"outlook\":\"Continued buying could push shares toward recent highs, though upside may moderate near resistance.\"},{\"day\":5,\"expected_close\":132.3,\"outlook\":\"The stock may extend its rise if it holds above the 130 area and sentiment remains supportive.\"}]"
}
```

## Rules of the trading agent

Please follow the following rules for entering in position :
- If the trade signal is BUY :
-- If we don't have this company in the portfolio, buy the company according your risk and portfolio strategy
-- If we already have this company, we can add more stock of this company only if the potential of win is significant

- If the trade signal is HOLD :
-- If we already have this company, do nothing. Adjust the stop loss if the actual stop loss is less than the new recommanded. Same for the traking profit
-- If we don't have this company in the portfolio and if the potential of win (target-actual price) is more than 3%, enter in position

- If the trade signal is SELL :
-- If we don't have this company in the portfolio :
--- If short selling is disabled (default, SHORT_SELLING_ENABLED=False), do nothing. We don't support Margin Account yet
--- If short selling is enabled, open a short position according to the same risk and portfolio strategy as a BUY entry (mirrored: stop above entry, target below entry)
-- If we already have a long position in this company, sell the stocks (close the position)
-- If we already have a short position in this company, we can add more to the short only if the potential of win is significant (mirrors the BUY scale-in rule)

- If the trade signal is BUY and we already hold a short position in this company : cover (close) the short, symmetric to a SELL signal closing a long


Please follow the following rules for risk management :
- Do not risk more than 2% of the total portfolio per position
- Do not let a single position's market value exceed 2% of the total portfolio (configurable via MAX_POSITION_SIZE_PCT)
- Do not enter in position if more than 60% of the portfolio is only used
- if the PnL for the current day is more than 10%, please use a circuit breaker and do not enter in position until tomorrow
- Only enter in position, if the volume per day is significant, we are talking about between 5 or 10 millions of dollay per day
- Preferred stocks (configurable list, PREFERRED_SYMBOLS) are allowed to push total portfolio utilization past MAX_PORTFOLIO_UTILIZATION_PCT by an extra configurable amount (PREFERRED_SYMBOL_EXTRA_UTILIZATION_PCT, default 10%) when a signal comes in for one of them
- Portfolio reorientation (configurable, PORTFOLIO_REORIENT_ENABLED, default on): if the portfolio is already fully booked (at MAX_PORTFOLIO_UTILIZATION_PCT) and a new signal's potential PnL is more profitable than our worst-performing open position's unrealized P&L by at least REORIENT_MIN_EDGE_PCT, sell that worst position to free up room instead of letting the more profitable signal go unacted on
